Topic

Aetna (CVS Health)

A collection of 1351 issues

How to Get Retevmo (selpercatinib) Covered by Aetna (CVS Health) in Michigan: Decision Tree, Forms & Appeals Guide

Answer Box: Quick Path to Retevmo Coverage To get Retevmo (selpercatinib) covered by Aetna (CVS Health) in Michigan: First, confirm you have FDA-validated RET alteration testing via RNA-based NGS (like FoundationOne CDx). Submit prior authorization through your provider with complete medical records showing RET-positive cancer diagnosis, prior therapy failures if
5 min read

Aetna (CVS Health) Coverage Criteria for Onivyde (Irinotecan Liposome) in North Carolina: What Counts as "Medically Necessary"?

Answer Box: Getting Onivyde Covered by Aetna (CVS Health) in North Carolina Aetna requires prior authorization for Onivyde (irinotecan liposome) with strict medical necessity criteria. You must have metastatic pancreatic adenocarcinoma, ECOG performance status 0-1, adequate biliary drainage, and documented failure of gemcitabine-based therapy. Submit PA via Aetna's
6 min read

How to Get Darzalex / Darzalex Faspro (daratumumab) Covered by Aetna (CVS Health) in Virginia: Complete Guide to Prior Authorization, Appeals, and State Protections

Answer Box: Your Fastest Path to Coverage Getting Darzalex / Darzalex Faspro (daratumumab) covered by Aetna (CVS Health) in Virginia requires prior authorization and often step therapy compliance. Your oncologist must document that bortezomib (the preferred agent) has failed or is contraindicated. Submit Aetna's precertification form via phone (1-866-752-7021)
6 min read